GSK Supports Emphasis on Asthma Control and Use of Quick ... - PR Newswire (press release)

Tue, 11 Sep 2007 00:15:52 +0000

GSK Supports Emphasis on Asthma Control and Use of Quick ...
PR Newswire (press release), NY -Aug 29, 2007
Advair Diskus is available by prescription only and is approved for the maintenance treatment of asthma in patients four years of age and older. ...

GSK receives FDA 'not approvable letter' for Advair for COPD - News-Medical.net

GSK receives FDA 'not approvable letter' for Advair for COPD
News-Medical.net, Australia -Aug 12, 2007
Advair Diskus may increase this risk, therefore, bone mineral density assessment is recommended prior to starting Advair Diskus and periodically thereafter. ...

Pharma Sector: Few Newsmakers Of The Week - Wyeth, Glaxo, Active ... - Trading Markets

Pharma Sector: Few Newsmakers Of The Week - Wyeth, Glaxo, Active ...
Trading Markets, CA -

Servier Drug Lowers Blood Pressure, Heart Risk in Diabetics

Mon, 03 Sep 2007 23:16:06 +0000

Bloomberg - Sept. 2 (Bloomberg) -- Les Laboratoires Servier's Preterax lowered blood pressure in diabetics more than a dummy pill, and cut their risk of death from heart attacks and strokes in a study. The pill made by the privately owned French drugmaker ...

Gilchrist & Soames has initiated a worldwide voluntary recall of its 0 ...
eMaxHealth.com - FDA did not approve GlaxoSmithKline's supplemental 500/50 strength of Advair Diskus (fluticasone propionate and salmeterol inhalation powder). Proprietary Technology To Help Solve Drug-Discovery Challenges Bend Research announced a new initiative ...

FDA more wary of new drugs
Centre Daily - ... the FDA has cited safety or effectiveness questions in rejecting or delaying approval for experimental drugs including Novartis' diabetes drug Galvus, Sanofi-Aventis' weight-loss drug Zimulti, and even a higher dose of GlaxoSmithKline's Advair Diskus ...

Pharma Sector: Few Newsmakers Of The Week - Wyeth, Glaxo, Active ...
TradingMarkets.com - British drug giant Glaxosmithkline's hopes to expand labeling for Advair Diskus, which is used to control asthma and chronic obstructive pulmonary disease, appears to be a long shot at least for now with the FDA issuing a 'not approvable letter' for ...

Wednesday's Health Winners & Losers
Street.Com - Away from earnings, GlaxoSmithKline ( GSK - Cramer's Take - Stockpickr ) said Wednesday that it received a letter from the Food and Drug Administration rejecting a request to approve a higher dose of Advair Diskus for patients with chronic ... ...

FDA delays ruling on new Endo drug (Daily Local News)

Thu, 30 Aug 2007 00:16:31 +0000

TRENTON, N.J. (AP) — Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data.

GSK receives FDA 'not approvable letter' for Advair for COPD (News-Medical-Net)
GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) in the treatment of patients with chronic obstructive pulmonary disease (COPD).

GSK Receives Decision From FDA On Advair 500/50 For COPD (Medical News Today)
GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) in the treatment of patients with chronic obstructive pulmonary disease (COPD). [click link for full article]

Glaxo's Advair Diskus Inhaler Fails to Win Wider Use in U.S. (Bloomberg.com)
Aug. 8 (Bloomberg) -- GlaxoSmithKline Plc failed to win U.S. approval to market the strongest dose of the asthma inhaler Advair Diskus, the company's top-selling product, as a treatment for symptoms of a common lung disease often linked to smoking.

FDA's caution about new drugs may hurt firms (Fort Worth Star-Telegram)
By LINDA A. JOHNSON Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market in 2004, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. The impact Besides keeping off the market drugs that some patients might desperately need, the rejections have battered drug company ......

GSK receives FDA 'not approvable letter' for Advair for COPD

Sat, 25 Aug 2007 23:15:46 +0000

News-Medical.Net - GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate and salmeterol inhalation powder ...

Advair Diskus - Drug Description
HealthCentral.com - ADVAIR DISKUS 100/50, ADVAIR DISKUS 250/50, and ADVAIR DISKUS 500/50 are combinations of fluticasone propionate and salmeterol xinafoate. One active component of ADVAIR DISKUS is fluticasone propionate, a corticosteroid having the chemical name S ...

Man arrested over Victoria rapes
News.com.au - POLICE have arrested a 45-year-old man over a series of rapes between 1991 and 2004, which are believed to have occurred in metropolitan Melbourne and involved the victims being drugged. ANOTHER Australian has been arrested for drug possession on the ... ...

Asthma Medication: Learn more about asthma & asthma treatment

Sat, 25 Aug 2007 00:15:52 +0000

Asthma inhaler medication from GlaxoSmithKline that treats constriction and inflammation.

Advair Diskus (Fluticasone Propionate) drug description - prescription drugs and medications at RxList
Find Advair Diskus (Fluticasone Propionate) medication description and details on prescription drugs. ... should only prescribe ADVAIR DISKUS for patients not ...

Advair Diskus
Learn about the Advair Diskus, a maintenance or preventative treatment for children and adults with asthma and COPD. ... the breath-activated Advair Diskus. ...

How to use ADVAIR DISKUS 250/50
How to use ADVAIR DISKUS 250/50 to make sure you're using the inhaler correctly ... The benefit of using ADVAIR DISKUS for longer than 6 months has not been ...

advair diskus prescribing information
patients with asthma, physicians should only prescribe ADVAIR DISKUS for patients not ... in vitro test conditions, ADVAIR DISKUS delivers 93, 233, and 465 ......

Fluticasone/Salmeterol Combination Improves Survival in COPD

Fri, 24 Aug 2007 23:18:06 +0000

Medscape News - Patients were randomized to receive fluticasone propionate 500 g alone, salmeterol 50 g alone, a combination of the two drugs (Advair 500/50 Diskus, GlaxoSmithKline) bid or placebo. The primary end-point was mortality, with secondary endpoints of ...

GSK receives FDA 'not approvable letter' for Advair for COPD
News-Medical.Net - GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate and salmeterol inhalation powder ...

Advair Diskus - Drug Description
HealthCentral.com - ADVAIR DISKUS 100/50, ADVAIR DISKUS 250/50, and ADVAIR DISKUS 500/50 are combinations of fluticasone propionate and salmeterol xinafoate. One active component of ADVAIR DISKUS is fluticasone propionate, a corticosteroid having the chemical name S ...

Man arrested over Victoria rapes
News.com.au - POLICE have arrested a 45-year-old man over a series of rapes between 1991 and 2004, which are believed to have occurred in metropolitan Melbourne and involved the victims being drugged. ANOTHER Australian has been arrested for drug possession on the ... ...